Skip to main content

Advertisement

SpringerLink
Log in

Global outcomes and lessons learned in the management of Fournier’s gangrene from high-volume centres: findings from a literature review over the last two decades

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction

Fournier’s Gangrene (FG) carries a high mortality and morbidity with underreported short and long-term outcomes. Our aim was to perform a review of the recent literature to evaluate the short and long-term outcomes in patients with FG in the acute setting from large-scale studies.

Methods

A PubMed search was performed between January 2000 and December 2021 for studies reporting on patients with FG. Exclusion criteria included small samples (n < 100), review articles and animal studies. Primary outcomes of interest were mortality, number of operative episodes for surgical debridement and admission to intensive care unit (ICU). Other outcomes assessed included rate of faecal and urinary diversion, orchidectomy rate, penectomy rate and length of hospital stay.

Results

From a total of 1182 studies, 18 were eligible for inclusion and included in this review. In total, data were analysed from 13,903 FG patients. Mean inpatient mortality rate was 7.3% (range 4.7–40.4%). Mean number of surgical debridement operations performed was 1.8 (range 1.5–4.2). On average, 6.8% (range 3.6–50.5%) and 7% (range 1.2–53.2%) underwent faecal and urinary diversions, respectively. Mean rate of orchidectomy was 5.6%, with rate of penectomy being lower at 0.2%. The mean length of hospital stay was 18.5 days (range 13.0–26.6). On average, 17.5% (range 10.1%–67.5%) required ICU admission for at least a single-system support.

Conclusion

Our review from the past twenty years of literature suggests that the mortality for FG, whilst still high, has fallen compared to previous years. Whilst inpatient metrics are well-covered in the literature there is a lack of large-scale studies detailing long-term patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fournier JA (1988) Jean-Alfred Fournier 1832–1914. Gangrène foudroyante de la verge (overwhelming gangrene). Sem Med 1883. Dis Colon Rectum 131(12):984–894. doi: https://doi.org/10.1007/BF02554904

  2. El-Qushayri AE, Khalaf KM, Dahy A, Mahmoud AR, Benmelouka AY, Ghozy S, Mahmoud MU, Bin-Jumah M, Alkahtani S, Abdel-Daim MM (2020) Fournier’s gangrene mortality: a 17-year systematic review and meta-analysis. Int J Infect Dis 92:218–225. https://doi.org/10.1016/j.ijid.2019.12.030

    Article  PubMed  Google Scholar 

  3. Hatipoglu E, Demiryas S, Şimşek O, Sarıbeyoğlu K, Pekmezci S (2020) Fournier's gangrene: five years' experience from a single center in Turkey. Ulus Travma Acil Cerrahi Derg 26(2):235–241. doi: https://doi.org/10.14744/tjtes.2020.66805

  4. Ruiz-Tovar J, Córdoba L, Devesa JM (2012) Prognostic factors in Fournier gangrene. Asian J Surg 35(1):37–41. https://doi.org/10.1016/j.asjsur.2012.04.006

    Article  PubMed  Google Scholar 

  5. Sorensen MD, Krieger JN (2016) Fournier’s Gangrene: epidemiology and outcomes in the general US population. Urol Int 97(3):249–259. https://doi.org/10.1159/000445695

    Article  PubMed  Google Scholar 

  6. Ngugi P, Magoha G, Nyaga P (2014) Fournier’s ganrene in the HIV era. Afr Health Sci 14(4):1063–1068. https://doi.org/10.4314/ahs.v14i4.38

    Article  PubMed  PubMed Central  Google Scholar 

  7. Singh A, Ahmed K, Aydin A, Khan MS, Dasgupta P (2016) Fournier's gangrene. A clinical review. Arch Ital Urol Androl 88(3):157–164. doi: https://doi.org/10.4081/aiua.2016.3.157

  8. Eke N (2000) Fournier’s gangrene: a review of 1726 cases. Br J Surg 87(6):718–728. https://doi.org/10.1046/j.1365-2168.2000.01497.x

    Article  CAS  PubMed  Google Scholar 

  9. Elliott D, Kufera JA, Myers RA (2000) The microbiology of necrotizing soft tissue infections. Am J Surg 179(5):361–366. https://doi.org/10.1016/s0002-9610(00)00360-3

    Article  CAS  PubMed  Google Scholar 

  10. Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, Mammen K (2006) Fournier’s gangrene and its emergency management. Postgrad Med J 82(970):516–519. https://doi.org/10.1136/pgmj.2005.042069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shyam DC, Rapsang AG (2013) Fournier’s gangrene. Surgeon 11(4):222–232. https://doi.org/10.1016/j.surge.2013.02.001

    Article  PubMed  Google Scholar 

  12. Boughanmi F, Ennaceur F, Korbi I, Chaka A, Noomen F, Zouari K (2021) Fournier’s gangrene: its management remains a challenge. Pan Afr Med J 12(38):23. https://doi.org/10.11604/pamj.2021.38.23.25863

    Article  Google Scholar 

  13. Stone HH, Martin JD Jr (1972) Synergistic necrotizing cellulitis. Ann Surg 175(5):702–711. https://doi.org/10.1097/00000658-197205000-00010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Stephens BJ, Lathrop JC, Rice WT, Gruenberg JC (1993) Fournier’s gangrene: historic (1764–1978) versus contemporary (1979–1988) differences in etiology and clinical importance. Am Surg 59(3):149–154

    CAS  PubMed  Google Scholar 

  15. Pawłowski W, Wroński M, Krasnodebski IW (2004) Zgorzel Fourniera [Fournier’s gangrene]. Pol Merkur Lekarski 17(97):85–87

    PubMed  Google Scholar 

  16. Creta M, Longo N, Arcaniolo D, Giannella R, Cai T, Cicalese A, De Nunzio C, Grimaldi G, Cicalese V, De Sio M, Autorino R, Lima E, Fedelini P, Marmo M, Capece M, La Rocca R, Tubaro A, Imbimbo C, Mirone V, Fusco F (2020) Hyperbaric oxygen therapy reduces mortality in patients with Fournier's Gangrene. Results from a multi-institutional observational study. Minerva Urol Nefrol 72(2):223–228. doi: https://doi.org/10.23736/S0393-2249.20.03696-6

  17. Jones P, Pietropaolo A, Chew BH, Somani BK (2021) Atlas of scoring systems, grading tools, and nomograms in endourology: a comprehensive overview from the TOWER Endourological Society Research Group. J Endourol 35(12):1863–1882. https://doi.org/10.1089/end.2021.0124

    Article  PubMed  Google Scholar 

  18. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI (1995) Outcome prediction in patients with Fournier’s gangrene. J Urol 154(1):89–92

    Article  CAS  Google Scholar 

  19. Doluoğlu ÖG, Karagöz MA, Kılınç MF, Karakan T, Yücetürk CN, Sarıcı H, Özgür BC, Eroğlu M (2016) Overview of different scoring systems in Fournier’s Gangrene and assessment of prognostic factors. Turk J Urol 42(3):190–196. https://doi.org/10.5152/tud.2016.14194

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wirjopranoto S, Azmi YA (2022) Outcome management of Fournier’s gangrene cases at tertiary hospital: 7 years experience. Urologia 89(1):104–107. https://doi.org/10.1177/03915603211046483

    Article  PubMed  Google Scholar 

  21. Corcoran AT, Smaldone MC, Gibbons EP, Walsh TJ, Davies BJ (2008) Validation of the Fournier’s gangrene severity index in a large contemporary series. J Urol 180(3):944–948. https://doi.org/10.1016/j.juro.2008.05.021

    Article  CAS  PubMed  Google Scholar 

  22. Yeniyol CO, Suelozgen T, Arslan M, Ayder AR (2004) Fournier’s gangrene: experience with 25 patients and use of Fournier’s gangrene severity index score. Urology 64(2):218–222. https://doi.org/10.1016/j.urology.2004.03.049

    Article  PubMed  Google Scholar 

  23. Morais H, Neves J, Maciel Ribeiro H, Ferreira M, Guimarães N, Azenha N, Dias R, Fonseca A, Conceição L (2017) Case series of Fournier’s gangrene: affected body surface area—the underestimated prognostic factor. Ann Med Surg (Lond) 27(16):19–22. https://doi.org/10.1016/j.amsu.2017.02.043

    Article  Google Scholar 

  24. Tuncel A, Aydin O, Tekdogan U, Nalcacioglu V, Capar Y, Atan A (2006) Fournier’s gangrene: three years of experience with 20 patients and validity of the Fournier’s Gangrene Severity Index Score. Eur Urol 50(4):838–843. https://doi.org/10.1016/j.eururo.2006.01.030

    Article  PubMed  Google Scholar 

  25. Yilmazlar T, Ozturk E, Ozguc H, Ercan I, Vuruskan H, Oktay B (2010) Fournier’s gangrene: an analysis of 80 patients and a novel scoring system. Tech Coloproctol 14(3):217–223. https://doi.org/10.1007/s10151-010-0592-1

    Article  CAS  PubMed  Google Scholar 

  26. Üreyen O, Acar A, Gökçelli U, Atahan MK, İlhan E (2017) Usefulness of FGSI and UFGSI scoring systems for predicting mortality in patients with Fournier’s gangrene: a multicenter study. Ulus Travma Acil Cerrahi Derg 23(5):389–394. https://doi.org/10.5505/tjtes.2017.71509

    Article  PubMed  Google Scholar 

  27. Egin S, Kamali S, Hot S, Gökçek B, Yesiltas M (2020) Comparison of mortality in Fournier’s Gangrene with the two scoring systems. J Coll Physicians Surg Pak 30(1):67–72. https://doi.org/10.29271/jcpsp.2020.01.67

    Article  PubMed  Google Scholar 

  28. Roghmann F, von Bodman C, Tian Z, Brock M, Löppenberg B, Braun K, Hinkel A, Palisaar J, Noldus J (2013) Vorhersage der Erkrankungsschwere von Patienten mit Fournier-Gangrän [Outcome prediction in patients with Fournier's gangrene]. Urologe A 52(10):1422–1429. doi: https://doi.org/10.1007/s00120-013-3173-x

  29. Yalçınkaya S, Yıldız A, Yüksel M, İslamoğlu E, Ateş N, Tokgöz H, Savaş M (2019) Can we predict mortality in patients with Fournier’s Gangrene using questionnaires? A pilot study with eighty-seven patients. J Urol Surg 6:118–124

    Article  Google Scholar 

  30. García Marín A, Turégano Fuentes F, Cuadrado Ayuso M, Andueza Lillo JA, Cano Ballesteros JC, Pérez López M (2015) Predictive factors for mortality in Fournier’ gangrene: a series of 59 cases. Cir Esp 93(1):12–17. https://doi.org/10.1016/j.ciresp.2014.03.017

    Article  PubMed  Google Scholar 

  31. Lin TY, Ou CH, Tzai TS, Tong YC, Chang CC, Cheng HL, Yang WH, Lin YM (2014) Validation and simplification of Fournier’s gangrene severity index. Int J Urol 21(7):696–701. https://doi.org/10.1111/iju.12426

    Article  CAS  PubMed  Google Scholar 

  32. Tenório CEL, Lima SVC, Albuquerque AV, Cavalcanti MP, Teles F (2018) Risk factors for mortality in fournier’s gangrene in a general hospital: use of simplified founier gangrene severe index score (SFGSI). Int Braz J Urol 44(1):95–101. https://doi.org/10.1590/S1677-5538.IBJU.2017.0193

    Article  PubMed  PubMed Central  Google Scholar 

  33. Yasri S, Wiwanitkit V (2018) Re: simplified Fournier’s gangrene severe index score (SFGSI). Int Braz J Urol 44(1):204. https://doi.org/10.1590/S1677-5538.IBJU.2017.0535

    Article  PubMed  PubMed Central  Google Scholar 

  34. Osbun N, Hampson LA, Holt SK, Gore JL, Wessells H, Voelzke BB (2017) Low-volume vs high-volume centers and management of Fournier’s Gangrene in Washington State. J Am Coll Surg 224(3):270-275.e1. https://doi.org/10.1016/j.jamcollsurg.2016.11.012

    Article  PubMed  Google Scholar 

  35. Eskitaşcıoğlu T, Özyazgan I, Coruh A, Günay GK, Altıparmak M, Yontar Y, Doğan F (2014) Experience of 80 cases with Fournier’s gangrene and “trauma” as a trigger factor in the etiopathogenesis. Ulus Travma Acil Cerrahi Derg 20(4):265–274. https://doi.org/10.5505/tjtes.2014.67670

    Article  PubMed  Google Scholar 

  36. Sugihara T, Yasunaga H, Horiguchi H, Fujimura T, Ohe K, Matsuda S, Fushimi K, Homma Y (2012) Impact of surgical intervention timing on the case fatality rate for Fournier’s gangrene: an analysis of 379 cases. BJU Int 110 (11 Pt C):E1096–E1100. doi: https://doi.org/10.1111/j.1464-410X.2012.11291.x

  37. Inácio M, Lima R, Neto S, Lopes F, Pantaroto M, de Sousa A (2020) Epidemiological study on Fournier syndrome in a tertiary hospital in Jundiaí-SP from October 2016 to October 2018. CC BY-NC-ND 4.0. J Coloproctol 40(01):37–42. doi: https://doi.org/10.1016/j.jcol.2019.10.005

  38. Ozturk E, Sonmez Y, Yilmazlar T (2011) What are the indications for a stoma in Fournier’s gangrene? Colorectal Dis 13(9):1044–1047. https://doi.org/10.1111/j.1463-1318.2010.02353.x

    Article  CAS  PubMed  Google Scholar 

  39. Akcan A, Sözüer E, Akyildiz H, Yilmaz N, Küçük C, Ok E (2009) Necessity of preventive colostomy for Fournier’s gangrene of the anorectal region. Ulus Travma Acil Cerrahi Derg 15(4):342–346

    PubMed  Google Scholar 

  40. Rosen DR, Brown ME, Cologne KG, Ault GT, Strumwasser AM (2016) Long-term follow-up of Fournier’s Gangrene in a tertiary care center. J Surg Res 206(1):175–181. https://doi.org/10.1016/j.jss.2016.06.091

    Article  PubMed  Google Scholar 

  41. Sarofim M, Di Re A, Descallar J, Toh JWT (2021) Relationship between diversional stoma and mortality rate in Fournier’s gangrene: a systematic review and meta-analysis. Langenbecks Arch Surg 406(8):2581–2590. https://doi.org/10.1007/s00423-021-02175-z

    Article  PubMed  Google Scholar 

  42. Li YD, Zhu WF, Qiao JJ, Lin JJ (2014) Enterostomy can decrease the mortality of patients with Fournier gangrene. World J Gastroenterol 20(24):7950–7954. https://doi.org/10.3748/wjg.v20.i24.7950

    Article  PubMed  PubMed Central  Google Scholar 

  43. Furr J, Watts T, Street R, Cross B, Slobodov G, Patel S (2017) Contemporary trends in the inpatient management of Fournier’s Gangrene: predictors of length of stay and mortality based on population-based sample. Urology 102:79–84. https://doi.org/10.1016/j.urology.2016.09.021

    Article  PubMed  Google Scholar 

  44. Kranz J, Schlager D, Anheuser P, Mühlstädt S, Brücher B, Frank T, Barski D, Mayr R, Lunacek A, Macharia-Nimietz EF, Steffens JA, Grolle J, Pelzer A, Schneidewind L (2018) Desperate need for better management of Fournier’s gangrene. Cent European J Urol 71(3):360–365. https://doi.org/10.5173/ceju.2018.1740

    Article  PubMed  PubMed Central  Google Scholar 

  45. Czymek R, Kujath P, Bruch HP, Pfeiffer D, Nebrig M, Seehofer D, Guckelberger O (2013) Treatment, outcome and quality of life after Fournier’s gangrene: a multicentre study. Colorectal Dis 15(12):1529–1536. https://doi.org/10.1111/codi.12396

    Article  CAS  PubMed  Google Scholar 

  46. Hasan AT, Fasihuddin Q, Sheikh MA (2002) Suprapubic cystostomy: urinary tract infection and other short term complications. J Pak Med Assoc 52(12):557–560

    CAS  PubMed  Google Scholar 

  47. Chawla SN, Gallop C, Mydlo JH (2003) Fournier’s gangrene: an analysis of repeated surgical debridement. Eur Urol 43(5):572–575. https://doi.org/10.1016/s0302-2838(03)00102-7

    Article  PubMed  Google Scholar 

  48. Lin TY, Cheng IH, Ou CH, Tsai YS, Tong YC, Cheng HL, Yang WH, Lin YM, Cheng YS (2019) Incorporating simplified Fournier’s Gangrene severity index with early surgical intervention can maximize survival in high-risk Fournier’s gangrene patients. Int J Urol 26(7):737–743. https://doi.org/10.1111/iju.13989

    Article  PubMed  Google Scholar 

  49. Laucks SS 2nd (1994) Fournier’s gangrene. Surg Clin North Am 74(6):1339–1352. https://doi.org/10.1016/s0039-6109(16)46485-6

    Article  PubMed  Google Scholar 

  50. Orakwe DE, Tijani KH, Jeje EA, Ogunjimi MA, Rufus WO, Alabi TO (2018) Bilateral subcapsular orchiectomy versus bilateral total orchiectomy: comparison of the quality of life post-orchiectomy. Niger Postgrad Med J 25(1):43–47. https://doi.org/10.4103/npmj.npmj_169_17

    Article  PubMed  Google Scholar 

  51. Lucas MD, Strijdom SC, Berk M, Hart GA (1995) Quality of life, sexual functioning and sex role identity after surgical orchidectomy in patients with prostatic cancer. Scand J Urol Nephrol 29(4):497–500. https://doi.org/10.3109/00365599509180033

    Article  CAS  PubMed  Google Scholar 

  52. Bandak M, Lauritsen J, Johansen C, Kreiberg M, Skøtt JW, Agerbaek M, Holm NV, Daugaard G (2020) Sexual function and quality of life in a national cohort of survivors of bilateral testicular cancer. Eur Urol Focus 6(4):711–719. https://doi.org/10.1016/j.euf.2018.11.007

    Article  PubMed  Google Scholar 

  53. Mäkelä EP, Roine RP, Taskinen S (2020) Paternity, erectile function, and health-related quality of life in patients operated for pediatric testicular torsion. J Pediatr Urol 16(1):44.e1-44.e4. https://doi.org/10.1016/j.jpurol.2019.10.008

    Article  Google Scholar 

  54. Kieffer JM, Djajadiningrat RS, van Muilekom EA, Graafland NM, Horenblas S, Aaronson NK (2014) Quality of life for patients treated for penile cancer. J Urol 192(4):1105–1110. https://doi.org/10.1016/j.juro.2014.04.014

    Article  PubMed  Google Scholar 

  55. Romero FR, Romero KR, Mattos MA, Garcia CR, Fernandes Rde C, Perez MD (2005) Sexual function after partial penectomy for penile cancer. Urology 66(6):1292–1295. https://doi.org/10.1016/j.urology.2005.06.081

    Article  PubMed  Google Scholar 

  56. Sosnowski R, Wolski JK, Kulpa M, Ziętalewicz U, Kosowicz M, Kalinowski T, Demkow T (2017) Assessment of quality of life in patients surgically treated for penile cancer: impact of aggressiveness in surgery. Eur J Oncol Nurs 31:1–5. https://doi.org/10.1016/j.ejon.2017.08.011

    Article  PubMed  Google Scholar 

  57. Monteiro LL, Skowronski R, Brimo F, Carvalho PDCN, Vasconcelos RAL, Pacheco CRCV, Calado AA, Kassouf W (2021) Erectile function after partial penectomy for penile cancer. Int Braz J Urol 47(3):515–522. https://doi.org/10.1590/S1677-5538.IBJU.2019.0119

    Article  PubMed  Google Scholar 

  58. Akbulut F, Kucuktopcu O, Sonmezay E, Simsek A, Ozgor F, Gurbuz ZG (2014) Partial penectomy after debridement of a Fournier’s gangrene progressing with an isolated penile necrosis. Ulus Travma Acil Cerrahi Derg 20(5):385–388. https://doi.org/10.5505/tjtes.2014.93636

    Article  PubMed  Google Scholar 

  59. Hoang D, Goel P, Chen VW, Carey J (2018) Phalloplasty following penectomy for Fournier’s Gangrene at a tertiary care center. Cureus 10(12):e3698. https://doi.org/10.7759/cureus.3698

    Article  PubMed  PubMed Central  Google Scholar 

  60. Carroll PR, Cattolica EV, Turzan CW, McAninch JW (1986) Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction. West J Med 144(2):174–178

  61. Kim SY, Dupree JM, Le BV, Kim DY, Zhao LC, Kundu SD (2015) A contemporary analysis of Fournier gangrene using the National Surgical Quality Improvement Program. Urology 85(5):1052–1057. https://doi.org/10.1016/j.urology.2014.08.063

    Article  PubMed  Google Scholar 

  62. Uluğ M, Gedik E, Girgin S, Celen MK, Ayaz C (2009) The evaluation of microbiology and Fournier’s gangrene severity index in 27 patients. Int J Infect Dis 13(6):e424–e430. https://doi.org/10.1016/j.ijid.2009.01.021

    Article  CAS  PubMed  Google Scholar 

  63. Castillejo Becerra CM, Jaeger CD, Rose JR, Beecroft NJ, Shah NC, Posid T, Jenkins LC, Baradaran N (2020) Microorganisms and antibiogram patterns in fournier’s gangrene: contemporary experience from a single tertiary care center. J Urol 204(6):1249–1255. https://doi.org/10.1097/JU.0000000000001194

    Article  PubMed  Google Scholar 

  64. Chen IC, Li WC, Hong YC, Shie SS, Fann WC, Hsiao CT (2011) The microbiological profile and presence of bloodstream infection influence mortality rates in necrotizing fasciitis. Crit Care 15(3):R152. https://doi.org/10.1186/cc10278

    Article  PubMed  PubMed Central  Google Scholar 

  65. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC (2014) Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis 59(2):147–159. https://doi.org/10.1093/cid/ciu296

    Article  PubMed  Google Scholar 

  66. Anaya DA, Dellinger EP (2007) Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis 44(5):705–710. https://doi.org/10.1086/511638

    Article  CAS  PubMed  Google Scholar 

  67. Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E (2011) Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. Clin Infect Dis 53(1):42–48. https://doi.org/10.1093/cid/cir301

    Article  PubMed  Google Scholar 

  68. Lauerman MH, Kolesnik O, Sethuraman K, Rabinowitz R, Joshi M, Clark E, Stein D, Scalea T, Henry S (2017) Less is more? Antibiotic duration and outcomes in Fournier’s gangrene. J Trauma Acute Care Surg 83(3):443–448. https://doi.org/10.1097/TA.0000000000001562

    Article  PubMed  Google Scholar 

  69. Fife CE, Eckert KA, Workman WT (2016) Ethical issues, standards and quality control in practice of hyperbaric medicine. In: Jain KK (ed) Textbook of hyperbaric medicine, 6th edn. Springer, New York

    Google Scholar 

  70. Fife CE, Eckert KA, Carter MJ (2016) An update on the appropriate role for hyperbaric oxygen: indications and evidence. Plast Reconstr Surg 138(3 Suppl):107S-116S. https://doi.org/10.1097/PRS.0000000000002714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Hadanny A, Meir O, Bechor Y, Fishlev G, Bergan J, Efrati S (2016) The safety of hyperbaric oxygen treatment—retrospective analysis in 2334 patients. Undersea Hyperb Med 43(2):113–122

    CAS  PubMed  Google Scholar 

  72. Liu R, Li L, Yang M et al (2013) Systematic review of the effectiveness of hyperbaric oxygenation therapy in the management of chronic diabetic foot ulcers. Mayo Clin Proc 88:166–175

    Article  CAS  Google Scholar 

  73. Thom SR (2011) Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg 127 (Suppl 1):131S–141S. doi: https://doi.org/10.1097/PRS.0b013e3181fbe2bf

  74. D’Agostino Dias M, Fontes B, Poggetti RS, Birolini D (2008) Hyperbaric oxygen therapy: types of injury and number of sessions—a review of 1506 cases. Undersea Hyperb Med 35(1):53–60

    CAS  PubMed  Google Scholar 

  75. Feres O, Feitosa MR, Ribeiro da Rocha JJ, Miranda JM, Dos Santos LE, Féres AC, de Camargo HP, Parra RS (2021) Hyperbaric oxygen therapy decreases mortality due to Fournier’s gangrene: a retrospective comparative study. Med Gas Res 11(1):18–23. https://doi.org/10.4103/2045-9912.310055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Tutino R, Colli F, Rizzo G et al (2022) Which role for hyperbaric oxygen therapy in the treatment of Fournier’s Gangrene? A retrospective study. Front Surg 9:850378. https://doi.org/10.3389/fsurg.2022.850378

    Article  PubMed  PubMed Central  Google Scholar 

  77. Theiss M, Hofmockel G, Eckert P, Frohmüller H (1996) Kosmetische und funktionelle Langzeitergebnisse nach Operation einer Fournier-Gangrän [Cosmetic and functional long-term outcome after operation of Fournier gangrene]. Urologe A 35(4):338–341

    CAS  PubMed  Google Scholar 

  78. Le Fouler A, Hamy A, Barbieux J, Souday V, Bigot P, Le Naoures P, Jaouen R Jr, Brochard C, Venara A (2018) Long-term functional outcomes of perineal gangrene: worse than expected?—an observational retrospective study. Int J Colorectal Dis 33(5):589–592. https://doi.org/10.1007/s00384-018-2999-5

    Article  PubMed  Google Scholar 

  79. Tripodi D, Amabile MI, Gagliardi F, Frusone F, Varanese M, De Luca A, Pironi D, D’Andrea V, Sorrenti S, Cannistrà C (2021) Algorithm of rational approach to reconstruction in Fournier’s disease. Open Med (Wars) 16(1):1028–1037. https://doi.org/10.1515/med-2021-0294

    Article  Google Scholar 

  80. Karian LS, Chung SY, Lee ES (2015) Reconstruction of defects after Fournier Gangrene: a systematic review. Eplasty 15:e18

    PubMed  PubMed Central  Google Scholar 

  81. Bhatnagar AM, Mohite PN, Suthar M (2008) Fournier’s gangrene: a review of 110 cases for aetiology, predisposing conditions, microorganisms, and modalities for coverage of necrosed scrotum with bare testes. N Z Med J 121(1275):46–56

    PubMed  Google Scholar 

  82. Carvalho JP, Hazan A, Cavalcanti AG, Favorito LA (2007) Relation between the area affected by Fournier’s gangrene and the type of reconstructive surgery used. A study with 80 patients. Int Braz J Urol 33(4):510–514. https://doi.org/10.1590/s1677-55382007000400008

    Article  PubMed  Google Scholar 

  83. Chen SY, Fu JP, Chen TM, Chen SG (2011) Reconstruction of scrotal and perineal defects in Fournier’s gangrene. J Plast Reconstr Aesthet Surg 64(4):528–534. https://doi.org/10.1016/j.bjps.2010.07.018

    Article  PubMed  Google Scholar 

  84. Tiwari IN, Seth HP, Mehdiratta KS (1980) Reconstruction of the scrotum by thigh flaps. Plast Reconstr Surg 66(4):605–607. https://doi.org/10.1097/00006534-198010000-00019

    Article  CAS  PubMed  Google Scholar 

  85. Insua-Pereira I, Ferreira PC, Teixeira S, Barreiro D, Silva Á (2020) Fournier’s gangrene: a review of reconstructive options. Cent Eur J Urol 73(1):74–79. https://doi.org/10.5173/ceju.2020.0060

    Article  Google Scholar 

  86. Radcliffe RS, Khan MA (2020) Mortality associated with Fournier’s gangrene remains unchanged over 25 years. BJU Int 125(4):610–616. https://doi.org/10.1111/bju.14998

    Article  PubMed  Google Scholar 

  87. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383. https://doi.org/10.1016/0021-9681(87)90171-8

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Nil.

Funding

Nil.

Author information

Authors and Affiliations

  1. University Hospital Southampton NHS Trust, Southampton, UK

    Daniel Bowen

  2. Department of Urology, Haukeland University Hospital, Bergen, Norway

    Patrick Juliebø-Jones

  3. Department of Clinical Medicine, University of Bergen, Bergen, Norway

    Patrick Juliebø-Jones

  4. Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK

    B. K. Somani

Authors
  1. Daniel Bowen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Patrick Juliebø-Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. K. Somani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

DB—project development, data collection, manuscript writing. PJ—data collection, manuscript editing. BKS—project coordination, manuscript editing.

Corresponding author

Correspondence to B. K. Somani.

Ethics declarations

Conflicts of interest

Nil.

Research involving Human Participants and/or Animals

As this is a systematic review, there is no primary research involving human participants and/or animals.

Informed consent

Not applicable as it is a review article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bowen, D., Juliebø-Jones, P. & Somani, B.K. Global outcomes and lessons learned in the management of Fournier’s gangrene from high-volume centres: findings from a literature review over the last two decades. World J Urol 40, 2399–2410 (2022). https://doi.org/10.1007/s00345-022-04139-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-022-04139-4

Keywords

Search

Navigation